Researchers at Boston University School of Medicine and Boston Medical Center have developed a blood test to diagnose membranous nephropathy in its early stages.

The test was developed by identifying an antigen protein that helps to identify and measure the amount of the antibodies in a blood sample.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Boston University School of Medicine assistant professor of medicine Laurence Beck said that identifying the presence of antibodies using a blood test has tremendous implications about who is treated with often toxic immunosuppressive drugs, and for how long.

“For the first time, a specific biomarker has been identified for this relatively common kidney disease,” Beck said.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact